Bajaj Healthcare Limited (BAJAJHCARE) - Total Assets
Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) holds total assets worth Rs8.39 Billion INR (≈ $90.72 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Bajaj Healthcare Limited shareholders equity for net asset value and shareholders' equity analysis.
Bajaj Healthcare Limited - Total Assets Trend (2011–2025)
This chart illustrates how Bajaj Healthcare Limited's total assets have evolved over time, based on quarterly financial data.
Bajaj Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Bajaj Healthcare Limited's total assets of Rs8.39 Billion consist of 58.3% current assets and 41.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.3% |
| Accounts Receivable | Rs2.52 Billion | 30.2% |
| Inventory | Rs1.62 Billion | 19.4% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs14.04 Million | 0.2% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Bajaj Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BAJAJHCARE market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bajaj Healthcare Limited's current assets represent 58.3% of total assets in 2025, an increase from 51.7% in 2011.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, up from 0.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 30.2% of total assets.
Bajaj Healthcare Limited Competitors by Total Assets
Key competitors of Bajaj Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
|
China | CN¥4.69 Billion |
|
KPC Pharmaceuticals Inc
SHG:600422
|
China | CN¥12.01 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117
|
China | CN¥1.91 Billion |
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
|
China | CN¥2.64 Billion |
Bajaj Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.75 | 1.66 | 1.27 |
| Quick Ratio | 1.17 | 1.21 | 0.85 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs2.03 Billion | Rs2.11 Billion | Rs464.53 Million |
Bajaj Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Bajaj Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.32 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 8.9% |
| Total Assets | Rs8.33 Billion |
| Market Capitalization | $114.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bajaj Healthcare Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bajaj Healthcare Limited's assets grew by 8.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bajaj Healthcare Limited (2011–2025)
The table below shows the annual total assets of Bajaj Healthcare Limited from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs8.33 Billion ≈ $90.09 Million |
+8.88% |
| 2024-03-31 | Rs7.65 Billion ≈ $82.75 Million |
-15.12% |
| 2023-03-31 | Rs9.01 Billion ≈ $97.49 Million |
+25.01% |
| 2022-03-31 | Rs7.21 Billion ≈ $77.98 Million |
+37.19% |
| 2021-03-31 | Rs5.26 Billion ≈ $56.85 Million |
+61.36% |
| 2020-03-31 | Rs3.26 Billion ≈ $35.23 Million |
+22.07% |
| 2019-03-31 | Rs2.67 Billion ≈ $28.86 Million |
-0.48% |
| 2018-03-31 | Rs2.68 Billion ≈ $29.00 Million |
+22.30% |
| 2017-03-31 | Rs2.19 Billion ≈ $23.71 Million |
+4.89% |
| 2016-03-31 | Rs2.09 Billion ≈ $22.60 Million |
+43.31% |
| 2015-03-31 | Rs1.46 Billion ≈ $15.77 Million |
+0.30% |
| 2014-03-31 | Rs1.45 Billion ≈ $15.73 Million |
+11.01% |
| 2013-03-31 | Rs1.31 Billion ≈ $14.17 Million |
+7.83% |
| 2012-03-31 | Rs1.21 Billion ≈ $13.14 Million |
+17.36% |
| 2011-03-31 | Rs1.04 Billion ≈ $11.19 Million |
-- |
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more